Analyzing the Implications of Healthcare Data Breaches through Computational Technique

The contributions of the Internet of Medical Things (IoMT), cloud services, information systems, and smart devices are useful for the healthcare industry. With the help of digital healthcare, our lives have been made much more secure and effortless and provide more convenient and accessible treatment. In current, the modern healthcare sector has become more significant and convenient for the purpose of both external and internal threats. Big data breaches affect clients, stakeholders, organisations, and businesses, and they are a source of concern and complication for security professionals. This research examines the many types and categories of big data breaches that companies face. In addition, the study's main purpose is to investigate and draw conclusions from healthcare big data breaches, with the goal of improving healthcare big data confidentiality. From the beginning of 2020-21, both years, practically our entire world moved online due to the COVID-19 pandemic. The coronavirus pandemic dramatically increased the extent of use of technology. Hacking/IT incidents, followed by unauthorised internal disclosures, are the most typical attacks behind healthcare data breaches, according to the report. This has become a main enticement for healthcare data theft and misuse. The number of healthcare big data breaches, the number of records exposed, and the resulting significant commercial losses are increasing. In the report, they analyze and investigate the number of healthcare big data breaches, the number of records exposed during the COVID-19 pandemic. Also, the study assesses the correctness of the datasets in order to achieve a dynamic digital healthcare data breaches environment using fuzzy based computational technique.

Multisystem inflammatory syndrome with persistent neutropenia in neonate exposed to SARS-CoV-2 virus: A case report and review of literature.

BACKGROUND: Multisystem inflammatory syndrome in Children (MIS-C) is a postinfectious immune mediated hyperinflammatory state seen in children and adolescent below 21 year of age and develop after 4-6 weeks of severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2) infection, however, it is rare in neonates. We report an extremely rare and first of its kind case of MIS-C in a neonate with persistent neutropenia. CASE DESCRIPTION: A 19-day old boy presented with complaints of fever and loose stools for 1 day and developed rash after admission. Baby was investigated for sepsis and commenced on IV antibiotics empirically. In view of persistent fever, diarrhoea, rash and absence of obvious microbial etiology of inflammation, with elevated inflammatory marker and an epidemiologic link to SARS-CoV-2 infection, the diagnosis of MIS-C-was made. Intravenous immunoglobulin (IVIg) was administered and defervescence occurred within 24 hours. He also developed neutropenia during course of illness which persisted on follow up. CONCLUSION: MIS-C in neonates is uncommon and fever with elevated inflammatory markers during COVID-19 pandemic should alert the pediatrician to the possibility of MIS-C. Neutropenia may be associated with MIS-C in neonates and warrants prolonged follow up.

Increased tracheostomy rates in head and neck cancer surgery during the COVID-19 pandemic.

Surgical practice during the coronavirus disease 2019 (COVID-19) pandemic has changed significantly, without supporting data. With increasing experience, a dichotomy of practice is emerging, challenging existing consensus guidelines. One such practice is elective tracheostomy. Here, we share our initial experience of head and neck cancer surgery in a COVID-19 tertiary care centre, emphasizing the evolved protocol of perioperative care when compared to pre-COVID-19 times. This was a prospective study of 21 patients with head and neck cancers undergoing surgery during the COVID-19 pandemic, compared to 193 historical controls. Changes in anaesthesia, surgery, and operating room practices were evaluated. A strict protocol was followed. One patient tested positive for COVID-19 preoperatively. There was a significant increase in pre-induction tracheostomies (28.6% vs 6.7%, P=0.005), median hospital stay (10 vs 7 days, P=0.001), and postponements of surgery (57.1% vs 27.5%, P=0.01), along with a significant decrease in flap reconstructions (33.3% vs 59.6%, P=0.03). There was no mortality and no difference in postoperative morbidity. No healthcare personnel became symptomatic for COVID-19 during this period. Tracheostomy is safe during the COVID-19 pandemic and rates have increased. Despite increased rescheduling of surgeries and longer hospital stays, definitive cancer care surgery has not been deferred and maximum patient and healthcare worker safety has been ensured.